Stemonix

Founded 

2014

 in 

Boston, Massachusetts
Stemonix is upending conventional drug development and toxicity testing by enabling researchers to quickly and economically conduct high-throughput toxicity and drug development studies in ready-to-assay plates containing functional microOrgans engineered from hiPSCs.

Ping Yeh - CEO, Co-Founder

Stay Tuned

Subscribe to our newsletter and get updates on our portfolio companies.